This third issue of DDup (Drug Discovery Update) is especially dedicated to our second collaboration with Harvard University regarding kidney diseases.

With CureNephron we have established the world leading initiative to address the causes of one of the most complex unmet medical
needs of our time. The kidney is clearly one of the most demanding organs in our body, so finding the right strategies and entry points to tackle situations like Chronic kidney disease (CDK) and other related diseases is the challenge that Harvard University and Evotec have taken up. We feel that as partners we are perfectly positioned to combine the scientific state of the art with the best-in class drug discovery infrastructures in order to accelerate the search for novel drug targets. We have started to build a systematic unbiased and comprehensive infrastructure that looks at the problem with a holistic view — we look for biomarkers
just as well as for novel pathways, mechanisms and drug targets.

Download the drug discovery update to learn more about kidney diseases at Evotec.